Search research articles
Contact Us
Filters
Showing results (21-30 of 93) with videos related to
Page
of 10
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2011
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome
Helge Stenvold, Tom Donnem, Sigve Andersen, et al.
Sarcoma
|
February 19, 2011
Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival
Thomas Karsten Kilvaer, Andrej Valkov, Sveinung W Sorbye, et al.
International Journal of Oncology
|
January 29, 2011
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas
Andrej Valkov, Sveinung Sorbye, Thomas K Kilvaer, et al.
Plos One
|
December 24, 2010
Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis
Thomas K Kilvaer, Andrej Valkov, Sveinung Sorbye, et al.
Plos One
|
March 11, 2011
The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas
Andrej Valkov, Sveinung W Sorbye, Thomas K Kilvaer, et al.
Plos One
|
May 24, 2011
Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2
Sigve Andersen, Tom Donnem, Khalid Al-Shibli, et al.
Anticancer Research
|
May 28, 2011
Correlation and coexpression of HIFs and NOTCH markers in NSCLC
Sigve Andersen, Tom Donnem, Samer Al-Saad, et al.
Journal of Translational Medicine
|
November 24, 2011
The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas
Andrej Valkov, Thomas K Kilvaer, Sveinung W Sorbye, et al.
Plos One
|
September 3, 2011
Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival
Sigve Andersen, Tom Donnem, Helge Stenvold, et al.
Cancer Medicine
|
October 25, 2013
Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
Tom Donnem, Jiangting Hu, Mary Ferguson, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 93) with videos related to
Sort By:
Page
of 10
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2011
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome
Helge Stenvold, Tom Donnem, Sigve Andersen, et al.
Sarcoma
|
February 19, 2011
Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival
Thomas Karsten Kilvaer, Andrej Valkov, Sveinung W Sorbye, et al.
International Journal of Oncology
|
January 29, 2011
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas
Andrej Valkov, Sveinung Sorbye, Thomas K Kilvaer, et al.
Plos One
|
December 24, 2010
Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis
Thomas K Kilvaer, Andrej Valkov, Sveinung Sorbye, et al.
Plos One
|
March 11, 2011
The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas
Andrej Valkov, Sveinung W Sorbye, Thomas K Kilvaer, et al.
Plos One
|
May 24, 2011
Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2
Sigve Andersen, Tom Donnem, Khalid Al-Shibli, et al.
Anticancer Research
|
May 28, 2011
Correlation and coexpression of HIFs and NOTCH markers in NSCLC
Sigve Andersen, Tom Donnem, Samer Al-Saad, et al.
Journal of Translational Medicine
|
November 24, 2011
The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas
Andrej Valkov, Thomas K Kilvaer, Sveinung W Sorbye, et al.
Plos One
|
September 3, 2011
Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival
Sigve Andersen, Tom Donnem, Helge Stenvold, et al.
Cancer Medicine
|
October 25, 2013
Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
Tom Donnem, Jiangting Hu, Mary Ferguson, et al.
Page
of 10